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Aims The generation of homogeneous cardiomyocyte populations from fresh tissue or stem cells is laborious and costly.
A potential solution to this problem would be to establish lines of immortalized cardiomyocytes. However, as pro-
liferation and (terminal) differentiation of cardiomyocytes are mutually exclusive processes, their permanent
immortalization causes loss of electrical and mechanical functions. We therefore aimed at developing conditionally
immortalized atrial myocyte (iAM) lines allowing toggling between proliferative and contractile phenotypes by a
single-component change in culture medium composition.
....................................................................................................................................................................................................
Methods
and results
Freshly isolated neonatal rat atrial cardiomyocytes (AMs) were transduced with a lentiviral vector conferring doxy-
cycline (dox)-controlled expression of simian virus 40 large T antigen. Under proliferative conditions (i.e. in the
presence of dox), the resulting cells lost most cardiomyocyte traits and doubled every 38 h. Under differentiation
conditions (i.e. in the absence of dox), the cells stopped dividing and spontaneously reacquired a phenotype very
similar to that of primary AMs (pAMs) in gene expression profile, sarcomeric organization, contractile behaviour,
electrical properties, and response to ion channel-modulating compounds (as assessed by patch-clamp and optical
voltage mapping). Moreover, differentiated iAMs had much narrower action potentials and propagated them at
>10-fold higher speeds than the widely used murine atrial HL-1 cells. High-frequency electrical stimulation of con-
fluent monolayers of differentiated iAMs resulted in re-entrant conduction resembling atrial fibrillation, which could
be prevented by tertiapin treatment, just like in monolayers of pAMs.
....................................................................................................................................................................................................
Conclusion Through controlled expansion and differentiation of AMs, large numbers of functional cardiomyocytes were gener-
ated with properties superior to the differentiated progeny of existing cardiomyocyte lines. iAMs provide an
attractive new model system for studying cardiomyocyte proliferation, differentiation, metabolism, and (electro)-
physiology as well as to investigate cardiac diseases and drug responses, without using animals.
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Introduction
Due to the limited availability of human heart tissue and the low mitotic
activity of postnatal human cardiomyocytes, cardiac research has
strongly relied on experiments in animals1,2 or with primary cardiomyo-
cytes of animal origin.3,4 The increasing opposition to the use of animals
for biomedical research has fuelled the search for alternative models of
human cardiac disease.
Recently, cardiomyocytes derived from pluripotent stem cells (PSC-
CMCs) have emerged as new models for studying different aspects of
cardiac disease. Despite the great potential of PSC-CMCs as cardiac
model systems, they have some serious drawbacks that need to be over-
come before becoming a practical alternative to the use of laboratory
animals. Both the generation of PSCs and the production of homoge-
neous populations of cardiomyocytes from these cells is a laborious,
time-consuming, and costly endeavour of varying efficiency, which
requires properly timed treatment of the starting material with different
cocktails of expensive growth factors and small molecules.5 Moreover,
PSCs greatly differ in their ability to differentiate into cardiomyocytes
and typically yield phenotypically heterogeneous populations of imma-
ture cardiac muscle cells.6,7 The latter feature is limiting the use of PSC-
CMCs in studying cardiac physiology and pathology, e.g. it has been
proven difficult to establish homogeneous (confluent) monolayers of
these cells for cardiac arrhythmia research by high-resolution optical
mapping.8
As another approach to reduce laboratory animal use in cardiac re-
search, cardiomyocyte lines have been generated using cardiac muscle
cells from rodents and humans as starting material and the simian virus 40
(SV40) large T (LT) antigen to induce cell proliferation.9–15 Unfortunately,
all cardiomyocyte lines generated thus far, including the widely used HL-1
cell line, display large structural, and functional deficits in comparison to
the primary cells from which they were indirectly derived.
In an attempt to overcome the paucity of cell lines with robust cardio-
myogenic differentiation capacity, we developed a new strategy to selec-
tively and conditionally immortalize cardiomyocytes. Given our special
interest in atrial fibrillation (AF) as the most common heart rhythm dis-
order in clinical practice,16 the recent discovery by members of our re-
search group that neonatal rat atrial cardiomyocytes (AMs) possess a
constitutively active acetylcholine-dependent Kþ current playing an im-
portant role in the development of AF17 and the relatively low cell yields
obtained from enzymatically dissociated neonatal rat atria, AMs were
chosen as starting material. These cells were transduced with a single
lentiviral vector (LV) allowing myocyte-restricted doxycycline (dox)/tet-
racycline-dependent LT expression followed by their clonal expansion in
the presence of dox. The resulting monoclonal cell lines were character-
ized by cell proliferation assays, reverse transcription-quantitative poly-
merase chain reaction (RT-qPCR) analysis, phase-contrast, and
immunofluorescence microscopy (IFM), western blotting, optical voltage
mapping, and patch-clamp. The response of the cells to cardiac ion chan-
nel inhibitors, and their ability to integrate with pAMs were also investi-
gated. Altogether, our data show that we have generated cardiomyocyte
lines that (i) outperform all existing lines of cardiac muscle cells in terms
of cardiomyogenic differentiation ability, (ii) have great potential as mod-
els for fundamental and applied cardiac research, and (iii) depending on
the specific application, may provide easy-to-use and cost-effective alter-
natives for PSC-CMCs and for cardiomyocytes freshly isolated from
animals.
Methods
Detailed methods are available in Supplementary material online.
Animal experiments
All animal experiments were approved by the Animal Experiments
Committee of Leiden University Medical Center (LUMC) and conformed to
the Guide for the Care and Use of Laboratory National Animals as stated by
the US Institutes of Health.
Cardiac cell culture
Neonatal rat cardiomyocytes were isolated and cultured essentially as
described.18
LV production
LV particles were produced using a previously published method.18 The mo-
lecular structure of the shuttle plasmid used for the production of the LT-
encoding LV is depicted in Figure 1A.
Molecular analyses
The primer pairs used for transcriptome analysis by RT-qPCR are shown in
Supplementary material online, Table S1.
Details about the antibodies used for western blotting and immunostain-
ing of formaldehyde-fixed cells are presented in Supplementary material on-
line, Table S2.
Apoptosis was studied using Alexa Fluor-568-conjugated annexin V.
Electrophysiological studies
Optical voltage mapping using 4-(2-(6-(dibutylamino)-2-naphthalenyl)
ethenyl)-1-(3-sulfopropyl)pyridinium hydroxide inner salt (di-4-ANEPPS) as
fluorescent voltage indicator was performed essentially as described previ-
ously.22 A detailed description of the whole-cell patch-clamp studies can be
found in the Supplementary material online.
Statistical analyses
Data were derived from a specified number (N) of observations from three dif-
ferent cell cultures. Unless otherwise stated, data were expressed as mean-
± standard deviation (SD), and SDs were represented by error bars. All data
were analysed with the nested analysis of variance (ANOVA) test using the
Real Statistics Resource Pack software (release 5.1, copyright 2013–2017,
Charles Zaiontz, www.real-statistics.com). For comparisons involving >2 exper-
imental groups, this test was followed by Bonferroni post hoc analysis. Results
were considered statistically significant at P-values <0.05. Statistical significance
was expressed as follows: *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001.
Results
Conditional immortalization of AMs
Low-density cardiomyocyte-enriched cultures of primary cells isolated
from the atria of 2-day-old Wistar rats were transduced with LV par-
ticles containing a dox-inducible LT expression unit based on the
monopartite lentiviral Tet-on system developed by Szulc et al.23 LT ex-
pression in this LV system was driven by the strong hybrid striated
muscle-specific MHCK7 promoter19 (Figure 1A) to minimize the likeli-
hood of inadvertently immortalizing the ±12% non-cardiomyocytes pre-
sent in the primary atrial cell cultures17 (data not shown).
In the presence of dox, cells started to divide forming clearly discern-
ible colonies at 1–3 weeks post-transduction (Figure 1B). Nine of >80
cell clones were randomly selected for testing the dox dependency of
their proliferation ability. Cells of all nine clones were actively dividing in
Differentiation-competent lines of atrial myocytes 1849
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the presence of dox and stopped doing so in its absence. To investigate
whether these clones contained excitable cells, confluent monolayers
were established, maintained in dox-free culture medium for 9 days and
examined by optical voltage mapping. Following 1-Hz electrical stimula-
tion, seven of the nine clones produced excitatory waves spreading from
the pacing electrode to the opposite site of the culture dishes. Of these
seven clones, clone no. 5 showed the shortest action potential (AP) du-
ration (APD) and highest conduction velocity (CV) and was therefore
picked for further investigation. Western blot analysis and IFM showed
expression of LT in this clone to be tightly and effectively controlled by
dox (Figure 1C–E).
Comparison of the light microscopic morphology of the conditionally
immortalized AMs (iAMs) with those of primary AMs (pAMs) revealed that
the surface area of proliferating iAMs did not significantly differ from that of
pAMs at culture day 1 (Figure 2A and E). Also, in near-confluent monolayers,
iAMs that were kept for 9 days in dox-free medium closely resembled
pAMs at culture day 9 in both size and appearance (Figure 2A).
In the presence of dox, 72.2± 8.1% of iAMs stained positive for the
proliferation marker Ki-67, which percentage dramatically decreased
upon dox removal (Figure 2B and F). Consistently, in the presence of
dox, iAMs proliferated with an average doubling time of 38 h, whereas
under differentiation conditions (i.e. in the absence of dox), the cell num-
ber slightly decreased with time (Figure 2G). As expected, in primary
atrial cell cultures, the percentage of a-actininþ cells expressing Ki-67
was very low indicating that the large majority of proliferating Ki-67þ
cells in these cultures are non-cardiomyocytes (Figure 2C and F). Probing
iAM cultures with fluorescently labelled annexin V for the presence of
surface-exposed phosphatidylserine as marker of apoptosis revealed
low signals in proliferating cultures, which slightly increased under differ-
entiation conditions (Figure 2D and H) but did not noticeably differ from
those in 9-day-old pAM cultures (Figure 2D and H).
Cardiomyogenic differentiation potential of
iAMs
The expression of cardiac marker genes in proliferating and differentiat-
ing iAM cultures was assessed by RT-qPCR analysis and compared with
that of pAMs and of primary neonatal rat ventricular cardiomyocytes
(pVMs) at culture day 9. Previous experience has shown that at this par-
ticular time point, the primary cardiomyocytes are optimally adapted to
the in vitro environment and still in an advanced state of differentia-
tion.17,18,22,24,25 Expression of the Nkx2.5, Gata4 and Mef2c genes, which
encode early cardiac transcriptional regulators, was higher in proliferat-
ing (i.e. Day 0) iAMs than in pAMs and pVMs and rapidly increased soon
after dox removal (Figure 3A). Expression of the sarcomeric protein-
encoding Actn2 and Myh6 genes, on the other hand, was lower in Day 0
iAMs than in pAMs and pVMs. Transcription of these genes also showed
a rapid increase under differentiation conditions to very similar levels as
in pAMs and pVMs (Figure 3A).
To study myofibrillogenesis, cells were immunostained for sarcomeric
a-actinin (Figure 3B). At the immortalized stage, a-actinin expression in
iAMs was low and in most cells the protein was diffusely spread through-
out the cytoplasm. However, in a few cells, a-actinin showed a punctate
staining pattern with the protein clustering in spherical or short elon-
gated structures. At Day 3 of differentiation, a-actinin formed longer
structures with a dot-like appearance reminiscent of immature myofi-
brils. Myofibril assembly nearly reached completion at Day 6 after dox
removal, with most of the a-actinin displaying the Z-line staining pattern
typical of cardiomyocytes. At the later stages of differentiation (i.e. at
Days 9 and 12 after dox removal), myofibrils underwent further matura-
tion resulting in cells with highly organized sarcomeres.
After dox removal, mRNA levels of the atrial natriuretic peptide
(ANP)-encoding Nppa gene, the atrial essential myosin light chain-
encoding Myl4 gene and the atrial regulatory myosin light chain (i.e.
Mlc2a)-encoding Myl7 gene were moderately (Myl4) to strongly (Nppa
and Myl7) upregulated in iAMs (Figure 3C). Moreover, neither in the ab-
sence nor in the presence of dox, iAMs expressed detectable amounts
of transcripts encoding ventricular regulatory myosin light chain (i.e.
Mlc2v; Myl2 gene), ventricular essential myosin light chain (Myl3 gene) or
b-myosin heavy chain (Myh7 gene; Figure 3C). The RNA samples of 9-
day-old pAM cultures contained high amounts of ‘atrial’ mRNA while
‘ventricular’ transcripts were barely detectable in these samples (Figure
3C). For the RNA samples from the 9-day-old pVM cultures the opposite
was true, i.e. they contained high amounts of Myl2, Myl3, and Myh7 tran-
scripts but hardly any Nppa, Myl4, or Myl7 mRNA (Figure 3C).
Collectively, these data indicate that iAMs reacquire properties of atrial
rather than ventricular cardiomyocytes when cultured in dox-free me-
dium (Figure 3C). Mlc2a immunostaining confirmed these findings and
showed gradual incorporation of this protein into sarcomeres indiscern-
ible from those in pAMs that had been cultured for 9 days (Figure 3D).
iAMs started to exhibit spontaneous contractions from Day 6 of differ-
entiation (Supplementary material online, Movie S1) demonstrating sar-
comere functionality. The immunostainings for a-actinin and Mlc2a also
revealed that the spontaneous differentiation of iAMs in the absence of
dox is a highly synchronous event occurring in essentially all cells at ap-
proximately the same time.
Electrophysiological properties of iAMs
RT-qPCRs targeting genes encoding cardiac ion channels showed an in-
crease in the mRNA levels of Scn5a/Nav1.5, Cacna1c/Cav1.2, Kcnj3/Kir3.1,
Kcnj5/Kir3.4, and Kcnj11/Kir6.2 during the early stages of iAM differentia-
tion, which, later in the differentiation process, dropped to approxi-
mately equal levels as in pAMs at culture day 9 (Supplementary material
online, Figure S1A–E). A similar differentiation-dependent trend in ex-
pression levels was observed for Kcnd3/Kv4.3 and Kcnh2/Kv11.1 but in
these cases transcript levels at the late stages of iAM differentiation were
higher than those in Day 9 pAMs (Supplementary material online, Figure
S1F and G). The iAMs did not express detectable amounts of Kcnj2/Kir2.1
at any stage in the differentiation process in contrast to pAMs that had
been cultured for 9 days (Supplementary material online, Figure S1H).
However, Kcnj2 expression in pAMs was much lower than in pVMs at
culture day 9. Transcript levels of the pacemaker channel genes Hcn2
and Hcn4 showed dynamic changes during the cardiomyogenic differen-
tiation of iAMs (Supplementary material online, Figure S1I and J).
Proliferating iAMs expressed more Hcn2 mRNA than pAMs at Day 9 of
culture, but this difference largely disappeared following 12 days of cardi-
omyogenic differentiation of the iAMs. The Hcn4 mRNA level in prolifer-
ating iAMs was lower than in pAMs at culture day 9 but showed a
gradual increase during the first 9 days of iAM differentiation to suddenly
drop afterwards. RT-qPCR analysis of Ryr2 and Atp2a2/Serca2 tran-
scripts showed an increase in the expression of these Ca2þ-handling
protein genes early during iAM differentiation. From Day 3 of differentia-
tion onwards, Ryr2 and Atp2a2 mRNA levels in iAMs remained constant
and were very similar (Ryr2) or 2- to 3-fold higher (Atp2a2) than in pAMs
at culture day 9 (Supplementary material online, Figure S1K and L).
Since spreading of APs through cardiac tissue critically depends on the
presence of intercellular conduits, iAM cultures at different stages of dif-
ferentiation were immunostained for the gap junction protein connexin
1850 J. Liu et al.
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..43 (Cx43). As shown in Figure 4A, Cx43 was first observed in iAMs at
3 days after dox removal and its amounts gradually increased as the cells
further differentiated. Initially, Cx43 was mainly detected in the perinu-
clear region (i.e. at the site of biosynthesis) but at Day 9 of differentiation,
most Cx43 was found in punctate patterns at the interfaces between
iAMs. To investigate the functionality of these gap junctional plaques,
confluent monolayers of differentiated iAMs were subjected to 1-Hz
electrical point stimulation, which caused the cells to contract at the
Figure 1 Conditional immortalization of pAMs. (A) Scheme of the procedure used for the reversible immortalization, amplification, and subsequent redif-
ferentiation of pAMs. (B) Bright-field images of a single cell in an LT-transduced pAM culture showing dox-dependent clonal expansion. (C–E) Analysis by
western blotting (C, D) and immunocytology (E) of LT protein expression in iAM cultures before (Day 0) and 3, 6, 9, and 12 days after dox removal.
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; A, atrium; Ori, bacterial origin of replication; AmpR, Escherichia coli ß-lactamase gene; LTR, human im-
munodeficiency virus type 1 (HIV1) long terminal repeat;W, HIV1 packaging signal; RRE, HIV1 Rev-responsive element; cPPT, HIV1 central polypurine tract
and termination site; MHCK7, chimeric striated muscle-specific promoter;19 LT, coding sequence of the temperature-sensitive mutant LT protein tsA58;20
IRES, encephalomyocarditis virus internal ribosome entry site; tTS, coding sequence of the hybrid tetracycline-controlled transcriptional repressor TetR-
KRAB;21 WHVPRE, woodchuck hepatitis virus posttranscriptional regulatory element; TRE, tetracycline-responsive promoter element consisting of 7
repeats of a 19-nucleotide tetracycline operator (tetO) sequence.
Differentiation-competent lines of atrial myocytes 1851
Figure 2 Morphology, proliferative activity, and apoptosis analysis of iAMs. (A) Bright-field images of proliferating iAMs (i.e. iAM-d0) and iAM-d9
and of pAMs at culture days 1 (pAM-d1) and 9 (pAM-d9). (B) Fluorescence images of proliferating iAMs and of iAMs at different days after dox removal
immunostained for the proliferation marker Ki-67. The arrow is pointing at the nucleus shown at a higher magnification in the inset. (C) Fluoromicrograph of
a 3-day-old pAM (pAM-d3) culture that was not subjected to mitomycin C treatment following double immunostaining for Ki-67 and sarcomeric a-actinin.
The Ki-67þ/a-actinin- cells observed in this culture mainly result from uninhibited proliferation of cardiac fibroblasts (data not shown). Arrows are pointing
at the nuclei shown at a higher magnification in the insets. (D) Fluorescence images of proliferating iAMs, of iAMs at different days after dox removal and of a
9-day-old, mitomycin C-treated pAM (pAM-d9) culture labelled with Alexa Fluor-568-conjugated annexin V to assess externalization of phosphatidylserine
as indicator of apoptosis. (E) Quantification of cell surface area of iAM-d0 and of pAM-d1. Data are presented as mean ± SD, n= 30 cells per experimental
group, each consisting of three cell preparations. For statistical analysis, the nested ANOVA test was used. (F) Graph showing the percentage of Ki-67þ nu-
clei in proliferating iAM cultures, in iAM cultures at different days after dox removal, and among the cardiomyocytes (i.e. a-actininþ cells) in pAM-d3 cultures.
Data are presented as mean ± SD, n= 12 cell cultures per experimental group from three individual preparations. Statistics was done using the nested
ANOVA test with Bonferroni post hoc correction. (G) Quantification of cell numbers in iAM cultures with or without dox. Data are presented as
mean ± SD, n= 3. (H) Quantification of cell surface-bound annexin V in proliferating iAM cultures, in iAM cultures at different days after dox removal and in
mitomycin C-treated pAM-d9 cultures. Data are presented as mean ± SD, n= 12 cell cultures per experimental group from three individual preparations.
Statistics was done using the nested ANOVA test with Bonferroni post hoc correction. **P< 0.01 vs. pAM cultures. AUs, arbitrary units.
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..pacing frequency (Supplementary material online, Movie S2). This result
was corroborated by optical voltage mapping, which showed uniform ra-
dial spreading of excitatory waves from the site of electrical point stimu-
lation in iAM cultures at Day 9 of differentiation (Supplementary
material online, Movie S3). Additional optical voltage mapping experi-
ments revealed a gradual increase in CV (Figure 4B and D; Supplementary
material online, Movie S3) and decrease in APD (Figure 4C, E, and F) with
ongoing iAM differentiation. As a matter of fact, CV and APD at 30% and
80% repolarization (APD30 and APD80, respectively) did not significantly
differ between iAM cultures at differentiation days 9 and 12 and 9-day-
old pAM cultures. These data suggest that upon dox removal, iAMs
differentiate into AMs with electrophysiological properties strongly re-
sembling those of pAMs.
To investigate the ionic basis of the similar electrophysiological prop-
erties of pAMs and cardiomyogenically differentiated iAMs as measured
by optical voltage, we conducted patch-clamp experiments on these car-
diomyocytes. The resting membrane potentials (RMP) of pAMs and
iAMs in monolayer culture did not significantly differ (-64.5 ± 1.2 mV,
Figure 3 Cardiomyogenic differentiation potential of iAMs. (A, C) Analysis by RT-qPCR of the expression of the cardiac transcription factor genes Nkx2.5,
Gata4, and Mef2c, the cardiac sarcomeric protein genes Actn2 and Myh6 (A), the ‘atrial’ genes Nppa, Myl4, and Myl7 and the ‘ventricular’ genes Myl2, Myl3,
and Myh7 (C) in pAMs and pVMs at Day 9 of culture and in iAMs on the indicated days of differentiation. mRNA levels are expressed relative to those in
9-day-old pAM (pAM-d9) cultures, which were set at 1. Data are presented as mean ± SD, n= 3. The low abundance of ‘atrial’ transcripts in pAM samples is
most likely due to the presence of some ventricular myocytes in these samples. Similarly, the pVM cultures may have contained low numbers of atrial myo-
cytes. Alternatively, pAMs may express ‘ventricular’ genes at low levels and pVMs may display low-level expression of ‘atrial’ genes. (B, D) Fluorescence
images of proliferating iAMs and of iAMs at different days after dox removal immunostained for sarcomeric a-actinin (red, B) or the atrial regulatory myosin
light chain MLC2a (green, D). pAMs and pVMs at culture day 9 served as positive and negative control for the MLC2a immunostaining, respectively. Cell nu-
clei have been visualized by staining with Hoechst 33342 (blue).
Differentiation-competent lines of atrial myocytes 1853
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..n= 15 vs. -67.5± 1.6 mV, n= 13), while single-cell recordings showed
pAMs to have a more negative RMP (-62.8 ± 1.8 mV, n= 14) than iAMs
(-46.0± 1.9 mV, n= 27; Supplementary material online, Figure S2A). In
spite of the measured difference in RMP between single pAMs and single
iAMs, both cell types were excitable and produced APs with very similar
characteristics under the same stimulation conditions (Supplementary
material online, Figure S2B and Table S3). Of all the AP parameters
assessed only the upstroke velocity and the overshoot were somewhat
smaller for the iAMs in comparison to the pAMs (Supplementary mate-
rial online, Table S3). In voltage-clamp experiments, we found that the
main membrane current responsible for the excitability of both cell types
is a fast voltage-activated transient Naþ current (consistent with the ex-
pression of Scn5a in these cells, Supplementary material online, Figure
S1A), which occurred in these cells as a dominant current component
(see Supplementary material online, Figure S2B, D, and E). Although these
patch-clamp results fit with the optical mapping data, we were puzzled
Figure 4 Electrophysiological properties of iAMs. (A) Fluorescence images of proliferating iAMs and of iAMs at different days after dox removal immunos-
tained for Cx43 (green) showing its differentiation-dependent accumulation at the sarcolemma in gap junctional plaques. As positive controls for the Cx43
immunostaining, 9-day-old pAM and pVM cultures were included. Hoechst 33342 (blue) staining shows cell nuclei. (B–F) Optical voltage mapping of conflu-
ent iAM and 9-day-old pAM (pAM-d9) monolayers following 1-Hz electrical point stimulation. (B, C) Typical activation maps (B, isochrones are separated by
6 ms) and optical signal traces (C) of iAM cultures at different days after dox removal showing an increase in CV and a decrease in APD with advancing iAM
differentiation. (D–F) Quantification of CV (D), APD30 (E), and APD80 (F) in pAM-d9 cultures and in iAM cultures at 3, 6, 9 and 12 days of differentiation.
Data are presented as mean ± SD, n= 12 cell cultures per experimental group from 3 individual preparations. Statistics was done using the nested ANOVA
test with Bonferroni post hoc correction. **P< 0.01 and ****P< 0.0001 vs pAM-d9 cultures. AUs, arbitrary units.
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by the similar RMPs for pAM and iAM monolayers, given the undetect-
able Kcnj2 expression in cardiomyogenically differentiated iAMs
(Supplementary material online, Figure S1H) and the presumed differ-
ence in the inward rectifier current between pAMs and iAMs (IK1;
Supplementary material online, Figure S2B). This apparent discrepancy
was resolved by showing, with the aid of ouabain, that the electrogenic
Naþ/Kþ ATPase plays an important role in generating hyperpolarized
RMPs in both pAMs and iAMs (Supplementary material online, Figure S3).
To investigate their ability to form a functional cardiac syncytium with
pAMs, iAMs were labelled with enhanced green fluorescent protein
(eGFP) by lentiviral transduction. Next, 1:1 co-cultures of pAMs treated
at Day 1 of culture with mitomycin C, and eGFP-labelled iAMs were
established and subsequently kept for 8 days in dox-free culture medium.
The co-cultures were compared with iAM monocultures at Day 9 of dif-
ferentiation and with 9-day-old, mitomycin C-treated pAM cultures
(Supplementary material online, Figure S4A). Cx43 immunostaining of the
co-cultures revealed the presence of gap junctions between iAMs and
pAMs (Supplementary material online, Figure S4B). Optical voltage map-
ping showed uniform radial spreading of APs from the pacing electrode
at roughly the same speed in all three culture types (Supplementary ma-
terial online, Figure S4C and D) suggesting proper electrical integration of
differentiated iAMs in co-cultures with pAMs.
Comparison of the electrophysiological
properties of iAMs and HL-1 cells
The electrophysiological properties of iAM clone no. 5 were compared
with those of the widely used HL-1 cell line, which was derived from the
AT-1 mouse atrial myocyte tumour lineage.11 To this end, confluent
monolayers of iAMs at Day 9 of differentiation and optimally maintained
confluent cultures of HL-1 cells were subjected to optical voltage map-
ping following 1-Hz pacing. The CV in the HL-1 cultures was ±20-fold
lower than in the iAM cultures (Figure 5A and B; Supplementary material
online, Movie S3), and HL-1 cells displayed greatly prolonged APs as com-
pared to differentiated iAMs (Figure 5C) characterized by a very slow up-
stroke. These data clearly demonstrate that differentiated iAMs possess
electrophysiological properties superior to those of HL-1 cells.
iAMs as in vitro model of AF
Our research group previously developed an in vitro model of AF based
on high-frequency electrical stimulation of confluent pAM cultures. The
resulting re-entrant circuits, or so-called rotors, could be terminated by
prolonging APD of the pAMs using the Kir3.x-specific inhibitor tertia-
pin.17 To determine whether confluent cultures of iAMs at different
stages of differentiation would display similar behaviour, they were burst
paced in the absence or presence of 100 nM tertiapin. While rotors
could be readily induced in iAM cultures from differentiation day 6 on-
wards (Figure 6A-C; Supplementary material online, Movie S4), re-entry
could not be established in iAM cultures at Day 3 of differentiation
(Figure 6C). Re-entry inducibility, the number of rotors per culture and
rotor frequency increased with the time after dox removal (Figure 6C–
E). After treatment with tertiapin, iAMs that had been cultured for 9 days
without dox showed a strong increase in APD (Figure 6F–H). Moreover,
in the presence of tertiapin it was no longer possible to induce re-entry
in confluent monolayers of iAMs at Days 6, 9, or 12 of differentiation by
burst pacing (Figure 6C–F). The fact that tertiapin treatment only slightly
reduced the CV in confluent monolayers of iAMs at Day 9 of differentia-
tion (from 20.5 to 19.8 cm/s; Figure 6I) suggests that Kir3.x channel
activity is not the major determinant of iAM excitability at the monolayer
level.
Discussion
Until now, all attempts to generate lines of cardiomyocytes that can give
rise to cells with electrical and contractile properties approaching those
of the starting material have failed. Indeed, all cardiomyocyte lines
reported to date display large structural and functional deficits compared
to the primary cardiomyocytes from which they were derived.11,13,15,26
In this study, we have solved this problem and describe the generation of
monoclonal lines of conditionally immortalized neonatal rat atrial myo-
cytes with preserved cardiomyogenic differentiation capacity. This was
accomplished by transducing pAMs with an LV directing myocyte-
selective and dox-dependent expression of the SV40 LT antigen.
Culturing of the resulting cells in medium with dox caused their rapid ex-
pansion, while in dox-free culture medium, the amplified cells spontane-
ously and synchronously differentiated into fully functional (i.e. excitable
and contractile) AMs that were successfully used to develop a mono-
layer model of AF, for investigating the APD-prolonging effects of toxins
(tertiapin, Figure 6). To provide our iAMs with a unique and easy-to-
remember identifier, we have dubbed the progeny of iAM clone no. 5
the iAM-1 cell line.
Properties of iAMs
RT-qPCR analysis of iAMs in different stages of differentiation (Figure 3
and Supplementary material online, Figure S1) showed a rapid increase in
mRNA levels of cardiac transcription factors, ion channels, Ca2þ-han-
dling proteins, and sarcomeric proteins shortly after dox removal. At
later stages of differentiation, these mRNA levels generally either stayed
fairly constant (as for the genes encoding cardiac transcription factors,
sarcomeric, and Ca2þ-handling proteins and ANP) or declined again to
the approximate mRNA levels of pAMs (Scn5a, Cacna1c, Hcn2, Kcnj3,
Kcnj11) and/or proliferating iAMs (Scn5a, Cacna1c, Kcnd3, Kcnh2, Kcnj3).
These findings are consistent with the notion that upon dox removal
iAMs rapidly engage in a cardiomyogenic differentiation programme with
the concomitant upregulation of genes needed to build a functional car-
diomyocyte. To complement the RT-qPCR data, we recently initiated an
RNA-seq study focussing on the transcriptomes of iAMs at different
stages of cardiomyogenic differentiation and subsequent dedifferentia-
tion. The results of this study will be presented elsewhere.
Following their differentiation in the absence of dox, iAMs acquire
properties of atrial rather than ventricular myocytes as evinced by the
high-level expression in differentiated iAMs of ‘atrial’ genes including
Nppa, Myl4, Myl7, Kcnj3, and Kcnj517 and the lack of expression of the
‘ventricular’ Myl2, Myl3, and Myh7 genes.27 Moreover, following 1-Hz pac-
ing, differentiated iAMs display rapid contractions that strongly resemble
those of pAMs but are quite different from the slower contractions of
pVMs (Supplementary material online, Movie S2 and data not shown).
Consistently, the average APD30 and APD80 of differentiated iAMs do not
significantly differ from those of pAMs (Figure 4E and F, respectively;
Supplementary material online, Table S3) but are much shorter than the
average APD30 and APD80 of pVMs (APD30 = 97.1± 13.6 ms and
APD80 = 242.8± 25.2 ms, n= 17). Collectively, these findings indicate that
although LT expression results in the dedifferentiation and proliferation
of AMs, the cells retain some kind of epigenetic memory causing them to
spontaneously differentiate into atrial myocytes upon dox removal.
Differentiation-competent lines of atrial myocytes 1855
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..RMPs of iAMs and pAMs
pAM and iAM monolayers had similar RMPs (Figure S2A). Although RMP
measurements of single cells are less reliable than those of cell clusters,
because the voltage is measured from a high-resistance source
(Rm > 100 MX) after establishing gigaseal, the RMPs of single pAMs and
pAM monolayers did not significantly differ (Figure S2A). However, the
RMP of single iAMs was significantly depolarized compared to that of
iAM monolayers (Figure S2A). Further experiments as part of a dedicated
patch-clamp study are needed to determine the precise cause for this
difference, which may, however, relate to the lack of Kcnj2 expression in
cardiomyogenically differentiated iAMs (Figure S1H) together with tech-
nical difficulties to perform meaningful RMP measurements in neonatal/
immature (atrial) cardiomyocytes due to their high plasma membrane
resistance.28,29
Our finding that the electrogenic Naþ/Kþ ATPase plays an important
role in the generation of the RMP of AMs is of particular interest, be-
cause it ensures a sufficiently negative RMP for the maintenance of excit-
ability of iAMs in monolayer cultures, in the absence of Kcnj2 expression.
The importance of the Naþ/Kþ pump for establishing physiological Naþ
and Kþ gradients is widely recognized in the electrophysiology of adult
cardiomyocytes. Decreased activity of the Naþ/Kþ pump under ischae-
mic conditions causes the loss of physiological Kþ and Naþ gradients
with consequent RMP depolarization and other effects favouring
arrhythmogenesis.30 However, as stated in many physiology textbooks,
a direct contribution of the electrogenic action of the Naþ/Kþ pump to
the RMP of adult cardiomyocytes is often considered as relatively small
compared to the pump’s indirect electrogenic effect, i.e. its ability to cre-
ate transmembrane Kþ and Naþ gradients. This may be understood by
considering the Naþ/Kþ pumps in the plasma membrane as a low con-
ductance pathway with a negative reversal potential determined by their
ATP-driven action.31,32 This implies that the direct electrogenic effects
of pump currents will, at the same current densities, be more prominent
in high-resistance (1 GX) cardiomyocytes like the AMs than in lower-
resistance (100 MX) cardiomyocytes like adult rat ventricular
cardiomyocytes.33 Possibly, no/low expression of inward rectifier Kþ
channels in iAMs and an important role for the Naþ/Kþ ATPase activity
in setting the RMP is characteristic for young (atrial) myocytes or a sign
of incomplete differentiation of these cells. Developmental increases in
IK1 are not uncommon and have previously been reported for ventricular
cardiomyocytes of various rodent species.34
Because of the dominance of voltage-activated Naþ channels in the
voltage-clamp recordings of both pAMs and iAMs, we ascribed the excit-
ability of iAMs mainly to those channels. However, AMs also express,
though at much lower levels, voltage-activated Ca2þ channels35
(Supplementary material online, Figure S1B), which may be expected to
contribute to pAM and iAM excitability. How these Ca2þ channels com-
pare in their contribution to excitability in pAMs and iAMs deserves fur-
ther experimental work. The same applies to the contributions of
outward rectifier Kþ currents to the excitability of pAMs and iAMs, and
to the realization of the RMP of single iAMs in general.
Possible applications of iAMs
Long-term culture of iAMs did not significantly reduce their proliferation
rate in the presence of dox and the sarcomeric organization and con-
tractile behaviour of iAMs from different passages at Day 9 of differentia-
tion were indistinguishable (data not shown). Moreover, no progressive
cell flattening, nuclear enlargement, development of senescence-
associated heterochromatin foci, or other signs of senescence were ob-
served during the first 55 population doublings of the cells. Assessment
of the electrophysiological properties of confluent monolayers of
Figure 5 Comparison by optical voltage mapping and 1-Hz electrical point stimulation of the electrophysiological properties of confluent monolayers of
iAMs at Day 9 of differentiation (iAM-d9) with those of HL-1 cells. Typical activation maps (A, 6-ms isochrone spacing) showing a much slower CV (B) and
optical signal traces (C) showing a much longer APD for the HL-1 cells as compared to the iAM-d9. Data are presented as mean ± SD, n= 9 cell cultures per
group from three individual preparations. For statistical analysis, the nested ANOVA test was used. ****P< 0.001. AUs, arbitrary units.
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differentiated iAMs by optical voltage mapping after 25, 40, and 55 popu-
lation doublings revealed no significant differences in APD or CV (see
Supplementary material online, Figure S5). Also, differentiated iAMs re-
sume cell division following addition of dox to the culture medium and
redifferentiate again into atrial myocytes following subsequent dox re-
moval (data not shown). iAMs therefore provide a virtually unlimited
supply of cardiomyocytes for fundamental research but may also prove
very useful for: (i) the development of acquired disease models, (ii) iden-
tifying new therapeutic targets, (iii) screening of drugs and toxins, (iv)
testing of new treatment modalities (e.g. gene and cell therapy), (v) pro-
duction of biopharmaceuticals in bioreactors or encapsulated cell/tissue
grafts, and (vi) the improvement of tissue engineering approaches. The
recent rapid progress in genome editing technologies36 will further ex-
pand the applicability of iAMs allowing them to be used as models for
studying key aspects of inherited cardiomyopathies.
A highly attractive feature of the iAMs is that they spontaneously un-
dergo cardiomyogenic differentiation in a synchronous and near
quantitative manner in standard culture medium without dox.
Contrarily, generation of cardiomyocytes from embryonic or induced
PSCs requires their properly timed treatment with various cocktails
of growth factors and small molecules.5 This typically yields phenotypi-
cally heterogeneous populations of mostly immature cardiomyocytes
contaminated with variable percentages of non-cardiomyocytes.
Consequently, to obtain relatively pure populations of PSC-CMCs
various different enrichment procedures have been developed.37
Production of more or less homogeneous populations of cardiomyo-
cytes from PSCs thus is a laborious, time-consuming, and costly endeav-
our as compared to the straightforward generation of atrial myocytes
from iAMs. This may explain why there are very few reports on the use
of PSC-CMCs to investigate cardiac arrhythmias in monolayer cultures
by optical mapping,8 while such experiments are easily performed with
differentiated iAM monolayers (Figures 4–6 and Supplementary material
online, Figures S3–S6). Also, in contrast to PSC-CMCs, iAMs offer the
possibility to study the molecular mechanisms involved in the transition
Figure 6 Suitability of iAMs as in vitro AF model assessed by optical voltage mapping. (A, F) Typical optical signal traces of mock- (A) and tertiapin (F)-
treated iAMs at Day 9 of differentiation (iAM-d9) after high-frequency (10–50 Hz) electrical point stimulation. (B) Activation maps (6-ms isochrone spacing)
of iAM-d9 cultures showing 1 (left) or 2 (right) re-entrant circuits. (C–E) Inducibility of re-entry (C), arrhythmia complexity (D) and quantification of rotor
frequency (E) in iAM cultures at 3, 6, 9, and 12 days of differentiation. (G) Typical optical AP records of mock- (black) and tertiapin (red)-treated iAM-d9 fol-
lowing 1-Hz pacing. (H and I) Quantification of APD30, APD80 (H) and CV (I) of mock- and tertiapin-treated iAM-d9. Data are presented as mean ± SD, in
n= 9 cell cultures per experimental group from three individual preparations. Statistics was done using the nested ANOVA test with Bonferroni post hoc
correction. **P< 0.01 and ****P< 0.0001 vs. control cultures. AUs, arbitrary units.
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of a differentiated cardiomyocyte that is no longer able to undergo cyto-
kinesis into an actively dividing cell. This is particularly relevant given the
growing interest in the regeneration of mammalian hearts from within by
stimulating cardiomyocytes surrounding the site(s) of cardiac injury to
multiply themselves through cell division.38,39 Current findings regarding
the molecular changes accompanying the reactivation of cardiomyocyte
proliferation should be interpreted with caution due to the presence of
other cell types (e.g. cardiac fibroblasts and inflammatory cells) in most
test materials. iAMs do not suffer from this drawback making them a po-
tentially highly useful model system to study the mechanisms underlying
cell cycle re-entry and progression of cardiomyocytes.
Optical voltage mapping of other clones of excitable iAMs yielded
very similar results although not all of them reached the same maximum
CV and minimum APD as clone no. 5 (e.g. clone no. 1 and no. 6;
Supplementary material online, Figure S6A–C and D–F, respectively). An
intriguing finding of this study is the difference in electrophysiological
properties between the differentiated progeny of different iAM clones,
which extends to iAM clones not presented in this study. The cause(s) of
this heterogeneity is/are unclear given the fact that cardiomyogenically
differentiated cells with a similarly high level of sarcomeric organization
still differed in electrophysiological behaviour (data not shown).
Therefore, besides a different propensity to mature, other factors might
explain the electrophysiological differences between individual iAM
clones. Different iAM clones may, for instance, be derived from different
parts of the atria (e.g. left or right atrium, epi- or endocardial atrium) or
represent different subtypes of atrial myocytes (i.e. nodal, bundle and
working cells). Also, the number and location of the chromosomal inser-
tion sites of the LV genomes and the cell’s epigenetic status at the mo-
ment of immortalization may have contributed to the observed
heterogeneity in electrophysiological properties between different iAM
clones.
Although single-cell patch-clamp analysis can yield a wealth of infor-
mation about the electrophysiological behaviour of individual cells and
has been widely used to estimate the risk of drug-induced proarrhyth-
mia, the technique does not directly assess proarrhythmic potential and
is of limited use for studying arrhythmia mechanisms. Optical mapping,
on the other hand, allows investigation of normal and disturbed cardiac
electrical impulse propagation in a direct manner with high spatial and
temporal resolution.40,41 As demonstrated by the experiments de-
scribed in Figures 4–6 and Supplementary material online, Figures S3–S6,
confluent iAM cultures are well-suited for optical mapping studies. In
combination with their large proliferation capacity, this opens perspec-
tives for developing high-throughput analyses based on the iAM lines
and/or future lines of other cardiomyocytes generated with our condi-
tional immortalization method.
Comparison between HL-1 and iAM-1 cells
Of all AM lines generated to date, the murine AM line HL-1 has the most
differentiated phenotype and is therefore most widely used. Side-by-side
comparison of the electrophysiological properties of confluent mono-
layers of differentiated iAM-1 cells and HL-1 cells by optical voltage map-
ping (Figure 5 and Supplementary material online, Movie S3) showed an
average CV for the HL-1 cultures of 1 cm/s, which is about 20-fold lower
than that of differentiated iAM-1 cell cultures and in line with previous
reports.26 Since Ma et al.42 reported a RMP of -77.7 ± 0.4 mV for HL-1
cells at an extracellular Kþ concentration of 4 mM, the low CV in conflu-
ent HL-1 cell monolayers does not seem to result from a high percent-
age of cardiac fast Naþ channels being in an inactivated state. The large
difference in CV between both cell types thus conceivably relates to the
fact that confluent HL-1 monolayers are a blend of proliferating cells
without cardiomyocyte functionality, which are electrically coupled to
cells that phenotypically resemble embryonic atrial myocytes.11
Conversely, in the iAM cultures at 9 days of differentiation virtually all
cells are in a similar advanced stage of differentiation forming a highly
conductive cardiac syncytium (Figures 4 and 5; Supplementary material
online, Figures S4–S6). Gap junctional coupling between undifferentiated
and differentiated cells may also explain the apparent discrepancy be-
tween the broad optical voltage traces of HL-1 cells in monolayer cul-
tures vs. the short APDs recorded for single HL-1 cells following whole-
cell current clamping.26
Conclusion
By employing a monopartite LV system allowing inducible expres-
sion of the SV40 LT antigen in cardiomyocytes, we have generated
lines of iAMs with (functional) properties superior to those of all
existing cardiomyocyte lines, none of which yields cells that ap-
proach the structural and functional maturity of dox-deprived
iAMs. This is especially true for differentiated iAM-1 monolayers,
which show homogeneous AP propagation at much higher speeds
than obtained with other lines of cardiac muscle cells. The broad
applicability of the iAMs was illustrated by their use (i) to study the
cardiac ion channel-modulatory activity of toxins and drugs and (ii)
as AF model. Since iAMs undergo a highly coordinated and precisely
timed cardiomyogenic differentiation process, they might also be
ideally suited to study specific aspects of cardiac muscle cell forma-
tion and maturation. Finally, because differentiation of iAMs into
electrically and mechanically active cardiomyocytes that phenotypi-
cally resemble atrial myocytes of new-born rats occurs spontane-
ously (i.e. without the need for complex treatment regimens with
expensive [bio]chemicals), iAMs may provide an easy-to-use and
cost-effective system to address specific fundamental and applied
cardiac research questions.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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